Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones

Journal of Rheumatology

Volumn 29, Issue 11, 2002, Pages 2299-2305

  Tengstrand, Birgitta ^a   Hafström, Ingiäld ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density; Estradiol; Men; Rheumatoid arthritis; Sulfasalazine; Testosterone

Indexed keywords

AURANOFIN; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN A; ESTRADIOL; ESTRONE; GOLD; METHOTREXATE; PENICILLAMINE; PODOPHYLLIN; PRASTERONE SULFATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE EROSION; BONE MINERAL; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATORY DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NONPARAMETRIC TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SMOKING; SMOKING HABIT;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; DEHYDROEPIANDROSTERONE SULFATE; DENSITOMETRY, X-RAY; DISABILITY EVALUATION; DISEASE PROGRESSION; ESTRADIOL; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; SULFASALAZINE; TESTOSTERONE;

EID: 0036842097     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Cortet B, Flipo RM, Duquesnoy B, Delcambre B. Bone tissue in rheumatoid arthritis. Bone mineral density and fracture risk. Rev Rhum Engl Ed 1995;62:197-204.
2. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: A review. Br J Rheumatol 1996;35:309-23.
3. Westhovens R, Dequeker J. Rheumatoid arthritis and osteoporosis. Z Rheumatol 2000;59 Suppl 1:33-8.
4. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721-8.
5. Laan RFJM, Buijs WCAM, Verbeek ALM, et al. Bone mineral density in patients with recent onset rheumatoid arthritis: Influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
6. Hansen M, Florescu A, Stoltenberg M, et al. Bone loss in rheumatoid arthritis. Scand J Rheumatol 1996;25:367-76.
7. Gough A, Sambrook P, Devlin J, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998;25:1282-9.
8. Saario R, Sonninen P. Mottonen T, Viikari J, Toivanen A. Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis. Influence of functional capacity and corticosteroid use. Scand J Rheumatol 1999;28:363-7.
9. Zheng MH, Wood DJ, Papadimitriou JM. What's new in the role of cytokines on osteoblast proliferation and differentiation? Pathol Res Pract 1992;188:1104-21.
10. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone mineral density in postmenopausal women. Arthritis Rheum 1993;36:1510-6.
11. Laan RFJM, van Riel PLCM, van de Putte LBA, van Erning LJTO, van't Hof MA, Lemmens JAM. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993;119:963-8.
12. Martin JC, Munro R, Campell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: Comparison with axial measurements. Br J Rheumatol 1997;36:43-9.
13. Verhoeven AC, Boers M. Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 1997;24:1495-503.
14. Sambrook P, Raj A, Hunter D, Naganathan V, Mason R, Robinson B. Osteoporosis with low dose corticosteroids: Contribution of underlying disease effects and the discriminatory ability of ultrasound versus bone densitometry. J Rheumatol 2001;28:1063-7.
15. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis occurs early and relates to disease activity. Lancet 1994;344:23-7.
16. Garton MJ, Reid DM. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids. Arthritis Rheum 1993;36:222-8.
17. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D. Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995;22:1455-60.
18. Stafford L, Bleasel J, Giles A, Handelsman D. Androgen deficiency and bone mineral density in men with rheumatoid arthritis. J Rheumatol 2000;27:2786-90.
19. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Reduced bone mineral density in male rheumatoid arthritis patients. Arthritis Rheum 2000;43:2776-84.
20. Gordon D, Beastall GH, Thomson JA, Sturrock RD. Androgenic status and sexual function in males with rheumatoid arthritis and ankylosing spondylitis. Q J Med 1986;60:671-9.
21. Spector TD, Ollier W, Perry LA, Silman AJ, Thompson PW, Edwards A. Free and serum testosterone levels in 276 males: A comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls. Clin Rheumatol 1989;8:37-41.
22. Tengstrand B, Carlström K, Hafström I. Bioavailable testosterone in men with rheumatoid arthritis - High frequency of hypogonadism. Rheumatology 2002;41:285-9.
23. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001;86:3555-61.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Prevoo ML, van't Hof MA, Kuper HH, van Leeuven MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
26. Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988;17:263-71.
27. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
28. Lunar Corp. Operators Manual, Expert-XL, Software Version 1.7. Madison, WI: Lunar Corp.; 1998.
29. World Health Organisation. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. WHO technical report series, 843. Geneva: WHO; 1994.
30. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
31. Haugeberg G, Uhlig T. Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 2000;43:522-30.
32. Pardridge WM. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 1986:15:259-78.
33. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral density in older US adults from NHANES III. J Bone Miner Res 1997;12:1761-8.
34. Legrand E, Chappard D, Pascaretti C, et al. Bone mineral density and vertebral fractures in men. Osteoporos Int 1999;10:265-70.
35. Evans SF, Davie MWJ. Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis 2000;59:269-75.
36. Kaufman JM, Johnell O, Abadie E, et al. Background for studies on the treatment of male osteoporosis: State of the art. Ann Rheum Dis 2000;59:765-72.
37. Ito M, Hayashi K, Yamada M, Uetani M, Nakamura T Relationship of osteophytes to bone mineral density and spinal fracture in men. Radiology 1993;189:497-502.
38. Sinigaglia L, Nervetti A, Mela Q, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. J Rheumatol 2000;27:2582-9.
39. Sambrook PN. The skeleton in rheumatoid arthritis: Common mechanisms for bone erosion and osteoporosis. J Rheumatol 2000;27:2541-2.
40. Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukaemia in remission. Cancer 1970;25:580-5.
41. Gnudi S, Butturini L, Ripamonti C, Avella M, Bacci G. The effects of methotrexate (MTX) on bone: A densitometric study conducted on 59 patients with MTX administered at different doses. Ital J Orthop Traumatol 1988;14:227-31.
42. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 1997;24:1489-94.
43. Mazzantini M, Di Munno O, Incerti-Vecchi L, Pasero G. Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 2000;18:327-31.
44. Mitra D, Elvins DM, Collins AJ. Testosterone and testosterone-free index in mild ankylosing spondylitis: Relationship with bone mineral density and vertebral fractures. J Rheumatol 1999;26:2414-7.
45. Drinka PJ, Olson J, Bawens S, Voeks SK, Carlson I, Wilson M. Lack of association between free testosterone and bone density separate from age in elderly men. Calcif Tissue Int 1993;52:67-9.
46. Hall GM, Perry LA, Spector TD. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann Rheum Dis 1993;52:211-4.
47. Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study. J Bone Miner Res 1997;12:1833-43.
48. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997;100:1755-9.
49. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women. A key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83:2266-74.
50. Kaufman JM. Androgens, bone metabolism and osteoporosis. In: Oddens J, Vermeulen A, editors. Androgens and the Ageing Male. New York: Parthenon Publishing Group; 1996;39-60.